Table 1.
Methadone-involved overdose deaths during March 2019 – February 2020 and April 2020 – March 2021.
| March 2019 – February 2020 |
April 2020 – March 2021a |
|||||
|---|---|---|---|---|---|---|
| All overdose deaths | All overdose deaths without methadone | Overdose deaths involving methadone | All overdose deaths | All overdose deaths without methadone | Overdose deaths involving methadone | |
| All | 72,809 (100 %) | 70,081 (100 %) | 2728 (100 %) | 97,487 (100 %) | 93,692 (100 %) | 3795 (100 %) |
| Sex | ||||||
| Female | 23,314 (32 %) | 22,158 (31.6 %) | 1156 (42.4 %) | 29,788 (30.6 %) | 28,255 (30.2 %) | 1533 (40.4 %) |
| Male | 49,495 (68 %) | 47,923 (68.4 %) | 1572 (57.6 %) | 67,699 (69.4 %) | 65,437 (69.8 %) | 2262 (59.6 %) |
| Race/ethnicity | ||||||
| Hispanic | 7822 (10.7 %) | 7545 (10.8 %) | 277 (10.2 %) | 11,499 (11.8 %) | 11,027 (11.8 %) | 472 (12.4 %) |
| Non-Hispanic Black | 11,036 (15.2 %) | 10,670 (15.2 %) | 366 (13.4 %) | 16,516 (16.9 %) | 15,941 (17 %) | 575 (15.2 %) |
| Non-Hispanic White | 51,338 (70.5 %) | 49,339 (70.4 %) | 1999 (73.3 %) | 65,575 (67.3 %) | 62,949 (67.2 %) | 2626 (69.2 %) |
| Otherb | 2613 (3.6 %) | 2527 (3.6 %) | 86 (3.2 %) | 3890 (4.0 %) | 3768 (4.0 %) | 122 (3.2 %) |
| Age | ||||||
| 0–19 | 1086 (1.5 %) | 1056 (1.5 %) | 30 (1.1 %) | 1902 (2.0 %) | 1854 (2.0 %) | 48 (1.3 %) |
| 20–29 | 11,783 (16.2 %) | 11,526 (16.4 %) | 257 (9.4 %) | 16,279 (16.7 %) | 15,928 (17 %) | 351 (9.2 %) |
| 30–39 | 18,779 (25.8 %) | 18,091 (25.8 %) | 688 (25.2 %) | 25,826 (26.5 %) | 24,913 (26.6 %) | 913 (24.1 %) |
| 40–49 | 15,523 (21.3 %) | 14,936 (21.3 %) | 587 (21.5 %) | 20,999 (21.5 %) | 20,130 (21.5 %) | 869 (22.9 %) |
| 50–59 | 15,654 (21.5 %) | 14,959 (21.3 %) | 695 (25.5 %) | 19,951 (20.5 %) | 19,043 (20.3 %) | 908 (23.9 %) |
| 60–69 | 7984 (11 %) | 7572 (10.8 %) | 412 (15.1 %) | 10,362 (10.6 %) | 9734 (10.4 %) | 628 (16.5 %) |
| 70+ | 1990 (2.7 %) | 1932 (2.8 %) | 58 (2.1 %) | 2154 (2.2 %) | 2077 (2.2 %) | 77 (2.0 %) |
| Co-involved substances | ||||||
| Synthetic opioidsc | 38,435 (52.8 %) | 37,435 (53.4 %) | 1000 (36.7 %) | 61,780 (63.4 %) | 60,066 (64.1 %) | 1714 (45.2 %) |
| Heroin | 13,916 (19.1 %) | 13,406 (19.1 %) | 510 (18.7 %) | 12,450 (12.8 %) | 11,838 (12.6 %) | 612 (16.1 %) |
| NSS | 12,044 (16.5 %) | 11,574 (16.5 %) | 470 (17.2 %) | 13,772 (14.1 %) | 13,126 (14 %) | 646 (17.0 %) |
| Benzodiazepines | 9927 (13.6 %) | 9169 (13.1 %) | 758 (27.8 %) | 12,700 (13 %) | 11,719 (12.5 %) | 981 (25.8 %) |
| Cocaine | 16,613 (22.8 %) | 16,181 (23.1 %) | 432 (15.8 %) | 20,273 (20.8 %) | 19,667 (21 %) | 606 (16.0 %) |
| Psychostimulantsd | 16,925 (23.2 %) | 16,553 (23.6 %) | 372 (13.6 %) | 26,512 (27.2 %) | 25,899 (27.6 %) | 613 (16.2 %) |
| Alcoholse | 10,318 (14.2 %) | 10,048 (14.3 %) | 270 (9.9 %) | 14,123 (14.5 %) | 13,725 (14.6 %) | 398 (10.5 %) |
a
Counts from January – March 2021 reflect provisional figures.
b
Includes non-Hispanic individuals of other races (including multiple races) and individuals for whom Hispanic ethnicity status is not stated.
c
ICD-10 code T40.4: synthetic opioids excluding methadone.
d
ICD-10 code T43.6: psychostimulants other than cocaine.
e
ICD-10 codes T51.0 and T51.9: ethanol and unspecified alcohols.